Cargando…

Wnt2 knock down by RNAi inhibits the proliferation of in vitro-cultured human keloid fibroblasts

To study the effect of knocking down wingless-related MMTV integration site 2 (Wnt2) expression by RNAi on the growth and signaling pathways of ex vitro-cultured keloid fibroblasts (KFB). Human KFB were isolated from 10 keloid patient specimens. The KFB cells were then transfected with 4 pairs of sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yumei, Yang, Weiqun, Pan, Mingmeng, Wang, Chaoyang, Wu, Wenyi, Zhu, Shize
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156062/
https://www.ncbi.nlm.nih.gov/pubmed/30212944
http://dx.doi.org/10.1097/MD.0000000000012167
Descripción
Sumario:To study the effect of knocking down wingless-related MMTV integration site 2 (Wnt2) expression by RNAi on the growth and signaling pathways of ex vitro-cultured keloid fibroblasts (KFB). Human KFB were isolated from 10 keloid patient specimens. The KFB cells were then transfected with 4 pairs of small interfering RNA (siRNA) targeting human Wnt2, respectively. Reverse transcriptase-polymerase chain reaction and Western blot analysis were conducted to verify the knock down of Wnt2, and the expression of β-catenin glycogen synthase kinase-3β (GSK-3β) and cyclin D1 were examined. siRNA Wnt2 transfection (siWnt2) resulted in the significant inhibition of Wnt2 expression at both the mRNA and protein levels. The expression of β-catenin, GSK-3β, p-GSK-3β, and cyclin D1 at the protein level also decreased in siWnt2 cells. siWnt2 resulted in a substantially slower growth and significant delay in cell doubling time of the KFB cells compared with control groups. Further, the siRNA knock down of GSK-3β and β-catenin resulted in slower proliferation rates, respectively. Wnt2 siRNA has an inhibitive effect on keloid fibroblast proliferation, which may be a potential therapeutic approach for keloid and other human fibrotic diseases.